Sunesis Pharmaceuticals (SNSS) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Financial Fact:
Research and development: 6.61M
Today's EPS Names:
ZTO, AMMX, AFIB, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q3 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $700 thousand versus the consensus estimate of $1.09 million.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TJX stock drops as profit outlook falls short of analyst estimates
- ZIM Integrated Shipping Services Ltd. (ZIM) Tops Q2 EPS by 82c
- Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
